Provided by Tiger Trade Technology Pte. Ltd.

Regeneron Pharmaceuticals

834.04
+7.400.90%
Post-market: 834.040.00000.00%19:58 EDT
Volume:786.92K
Turnover:656.91M
Market Cap:85.87B
PE:20.63
High:847.00
Open:835.74
Low:826.64
Close:826.64
52wk High:847.00
52wk Low:541.00
Shares:102.95M
Float Shares:98.88M
Volume Ratio:1.27
T/O Rate:0.80%
Dividend:3.64
Dividend Rate:0.44%
EPS(TTM):40.43
EPS(LYR):41.48
ROE:14.04%
ROA:6.53%
PB:2.71
PE(LYR):20.11

Loading ...

Sep 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 24, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 23, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 23, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 21, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 18, 2023

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
Aug 10, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 03, 2023

Major Issues Report

Form 8-K - Current report
Aug 03, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 03, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 03, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 15, 2023

Major Issues Report

Form 8-K - Current report
Jun 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 04, 2023

Major Issues Report

8-K - Current report
May 04, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 21, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 17, 2023

Major Issues Report

8-K - Current report
Apr 10, 2023

Major Issues Report

8-K - Current report